1. Home
  2. TK vs PCRX Comparison

TK vs PCRX Comparison

Compare TK & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$13.22

Market Cap

937.1M

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.77

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
PCRX
Founded
1973
2006
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
937.1M
1.0B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
TK
PCRX
Price
$13.22
$22.77
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$30.25
AVG Volume (30 Days)
453.2K
515.7K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
15.21%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
N/A
$6.78
Revenue Next Year
N/A
$8.54
P/E Ratio
$13.43
$336.79
Revenue Growth
N/A
26.04
52 Week Low
$7.12
$18.80
52 Week High
$14.38
$27.64

Technical Indicators

Market Signals
Indicator
TK
PCRX
Relative Strength Index (RSI) 51.19 41.55
Support Level $12.09 $22.13
Resistance Level $13.76 $24.20
Average True Range (ATR) 0.49 1.26
MACD -0.09 -0.25
Stochastic Oscillator 21.85 8.81

Price Performance

Historical Comparison
TK
PCRX

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: